| HIV infection: oral lesions, CD4 + cell count and viral load in an ltalian study population V Margiotta, G Campisi, S Mancuso, V Accurso, V Abbadessa Journal of oral pathology & medicine 28 (4), 173-177, 1999 | 168 | 1999 |
| Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP M Baccarani, E Abruzzese, V Accurso, F Albano, M Annunziata, S Barulli, ... Blood Advances 3 (24), 4280-4290, 2019 | 81 | 2019 |
| Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site: results of an Italian multicenter, randomized, phase II … S Palmeri, V Lorusso, L Palmeri, M Vaglica, C Porta, R Nortilli, F Ferraú, ... Cancer 107 (12), 2898-2905, 2006 | 65 | 2006 |
| The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or … A Morabito, G Filippelli, S Palmeri, S Cascinu, F Ferraù, V Zagonel, ... Breast cancer research and treatment 78, 29-36, 2003 | 44 | 2003 |
| The essential thrombocythemia in 2020: what we know and where we still have to dig deep V Accurso, M Santoro, S Mancuso, M Napolitano, M Carlisi, M Mattana, ... Clinical Medicine Insights: Blood Disorders 13, 2634853520978210, 2020 | 43 | 2020 |
| Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience. RA Novo G, Di Lisi D, Bronte E, Macaione F, Accurso V, Badalamenti G ... ONCOLOGY, 1-7, 2020 | 34* | 2020 |
| COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report M Breccia, E Abruzzese, V Accurso, I Attolico, S Barulli, M Bergamaschi, ... British Journal of Haematology, 2021 | 28 | 2021 |
| Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study V Accurso, M Santoro, S Raso, AD Contrino, P Casimiro, F Di Piazza, ... Hematology Reports doi.org/10.4081/hr.2019.8281 11 (4), 2019 | 28 | 2019 |
| Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the … N P. Comella, R. Casaretti, A. Avallone, M. Montella, G. Comella (National ... Annals of Oncology 3 (11), 866-873, 2002 | 23* | 2002 |
| Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review NGSS Santoro M, Mancuso S, Accurso V, Di Lisi D Front. Physiol 12, 2021 | 22 | 2021 |
| Cardiovascular risk in polycythemia vera: thrombotic risk and survival: can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk … S Mancuso, M Santoro, V Accurso, G Agliastro, S Raso, F Di Piazza, ... Oncology Research and Treatment 43 (10), 526-530, 2020 | 21 | 2020 |
| Cardiovascular risk in essential thrombocythemia and polycythemia vera: Thrombotic risk and survival V Accurso, M Santoro, S Mancuso, AD Contrino, P Casimiro, M Sardo, ... Mediterranean journal of hematology and infectious diseases 12 (1), 2020 | 20 | 2020 |
| HIV and discrimination. U Tirelli, V Accurso, M Spina, E Vaccher BMJ: British Medical Journal 303 (6802), 582, 1991 | 20 | 1991 |
| Low-dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs A Iurlo, D Cattaneo, A Malato, V Accurso, M Annunziata, A Gozzini, ... American Journal of Hematology 95 (10), E260-E263, 2020 | 18 | 2020 |
| Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial S Palmeri, V Leonardi, V Gebbia, MT De Bella, F Ferrau, G Faillu, ... Lung Cancer 34 (1), 115-123, 2001 | 18 | 2001 |
| Clinical implications of discordant early molecular responses in cml patients treated with imatinib S Stella, V Zammit, SR Vitale, MS Pennisi, M Massimino, E Tirrò, S Forte, ... International Journal of Molecular Sciences 20 (9), 2226, 2019 | 17 | 2019 |
| Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS‐related Kaposi's sarcoma M Tavio, E Vaccher, A Antinori, A Ammassari, M Cusini, M Fasan, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 16 | 1996 |
| Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) E Iannitto, V Accurso, M Federico, D Vallisa, C Pieresca, SF Gravina, ... Haematologica 82 (6), 676-682, 1997 | 13 | 1997 |
| Treatment of HIV-related non-Hodgkin's lymphoma (NHL) with chemotherapy (CT) and G-CSF: reduction in the days of hospitalization and toxicity with concomitant overall reduction … U Tirelli, D Errante, E Vaccher, M Tavio, V Accurso, D Bernardi Proc Am Soc Clin Oncol 12, 53, 1993 | 13 | 1993 |
| Management of ponatinib in patients with chronic myeloid leukemia with cardiovascular risk factors M Santoro, V Accurso, S Mancuso, AD Contrino, M Sardo, G Novo, ... Chemotherapy 64 (4), 205-209, 2019 | 11 | 2019 |
prof. sergio siragusaFull Professor of Hematology, University of Palermo, italy在 unipa.it 的电子邮件经过验证
